Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125463641 | 12546364 | 1 | I | 20160704 | 20160711 | 20160711 | EXP | IT-DSJP-DSE-2016-123654 | DAIICHI | VOLTA U, CAIO G, BOSCHETTI E, GIANCOLA F, RHODEN K J, RUGGERI E, ET AL. SERONEGATIVE CELIAC DISEASE: SHEDDING LIGHT ON AN OBSCURE CLINICAL ENTITY. DIGESTIVE AND LIVER DISEASE. 2016 | 0.00 | Y | 0.00000 | 20160711 | OT | IT | IT |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125463641 | 12546364 | 1 | PS | OLMESARTAN MEDOXOMIL. | OLMESARTAN MEDOXOMIL | 1 | Oral | U | 21286 | TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125463641 | 12546364 | 1 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125463641 | 12546364 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125463641 | 12546364 | Malabsorption |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |